1. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms

   • Mia J. Sullivan
   • Elizabeth L. Palmer
   • Juliana Perez Botero

   Germline Predisposition to Myeloid Neoplasms (M. Patnaik, Section Editor) 25 June 2022 Pages: 105 - 112

   

2. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms

   • Talha Badar
   • Timothy Chlon

   Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor) 04 July 2022 Pages: 113 - 120

   

3. Management of Chronic Myeloid Leukemia in Children and Young Adults

   • Maegan Ford
   • Michael Mauro
   • Nobuko Hijiya

   Chronic Myeloid Leukemias (V Oehler, Section Editor) Open access 03 August 2022 Pages: 121 - 126

4. Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms

   • Barbara Mora
   • Francesco Passamonti

   Myeloproliferative Neoplasms (P Bose, Section Editor) Open access 01 September 2022 Pages: 127 - 139

5. Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors

   • Julian A. Waksal
   • John Mascarenhas

   Myeloproliferative Neoplasms (P Bose, Section Editor) 19 August 2022 Pages: 140 - 154

   

6. Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia

   • Ivan Krecak
   • Marko Lucijanic
   • Srdan Verstovsek

   Myeloproliferative Neoplasms (P Bose, Section Editor) 06 August 2022 Pages: 155 - 169